Scott Akamine
2021
In 2021, Scott Akamine earned a total compensation of $3.2M as Chief Legal Officer and Corporate Secretary at Cerevel Therapeutics Holdings.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $118,907 |
| Option Awards | $2,749,997 |
| Salary | $260,536 |
| Other | $15,300 |
| Total | $3,194,740 |
Akamine received $2.7M in option awards, accounting for 86% of the total pay in 2021.
Akamine also received $50K in bonus, $118.9K in non-equity incentive plan, $260.5K in salary and $15.3K in other compensation.
Rankings
In 2021, Scott Akamine's compensation ranked 4,190th out of 12,415 executives tracked by ExecPay. In other words, Akamine earned more than 66.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,190 out of 12,415 | 66th |
Division Manufacturing | 1,725 out of 5,505 | 69th |
Major group Chemicals And Allied Products | 718 out of 2,375 | 70th |
Industry group Drugs | 640 out of 2,096 | 70th |
Industry Pharmaceutical Preparations | 451 out of 1,546 | 71st |
Source: SEC filing on April 28, 2022.
Akamine's colleagues
We found five more compensation records of executives who worked with Scott Akamine at Cerevel Therapeutics Holdings in 2021.
2021
N Coles
Cerevel Therapeutics Holdings
Chief Executive Officer
2021
Abraham Ceesay
Cerevel Therapeutics Holdings
President
2021
Kathy Yi
Cerevel Therapeutics Holdings
Chief Financial Officer
2021
Raymond Sanchez
Cerevel Therapeutics Holdings
Chief Medical Officer
2021
Mark Bodenrader
Cerevel Therapeutics Holdings